Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.49 USD | -1.32% | -4.26% | +69.43% |
May. 08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
Chart calendar Design Therapeutics, Inc.
Upcoming events on Design Therapeutics, Inc.
Past events on Design Therapeutics, Inc.
2024-05-08 04:05 pm | Q1 2024 Earnings Release |
2024-03-19 04:30 pm | Q4 2023 Earnings Call |
2024-03-19 04:01 pm | Q4 2023 Earnings Release |
2023-11-13 04:05 pm | Q3 2023 Earnings Release |
2023-08-14 04:30 pm | DT-216 Phase 1 Clinical Trial Results Call |
2023-08-14 04:05 pm | Q2 2023 Earnings Release |
2023-06-07 03:30 pm | Jefferies Global Healthcare Conference |
2023-05-30 | Annual General Meeting |
2023-05-09 04:05 pm | Q1 2023 Earnings Release |
2023-03-14 04:05 pm | Q4 2022 Earnings Release |
2023-02-15 05:00 pm | SVB Securities Global Biopharma Conference |
2022-12-07 04:30 pm | DT-216 Phase 1 SAD Trial Results Call |
2022-11-03 04:05 pm | Q3 2022 Earnings Release |
2022-11-03 10:15 am | International Congress for Ataxia Research Conference |
2022-09-29 03:30 pm | Jefferies Cell and Genetic Medicine Summit - Fireside Chat |
2022-08-10 10:20 am | Wedbush PacGrow Healthcare Conference |
2022-08-07 | Interim 2022 Earnings Release (Projected) |
2022-06-15 11:30 am | Annual General Meeting |
2022-06-08 08:30 am | Jefferies Healthcare Conference |
2022-05-18 09:30 am | RBC Capital Markets Global Healthcare Conference |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -35,7 -38,4 6.95% | -67,2 -67,9 1.11% | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -35,8 -37,4 4.17% | -67,6 -67,5 -0.18% | -78,2 -83,1 5.92% | -63,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -35,5 -36,1 1.61% | -63,3 -64,4 1.65% | -66,9 -74,1 9.74% | -66,9 |
Net income Million USD | Released Forecast Spread | -8,28 | -35,5 -36,5 2.54% | -63,3 -65,3 3.02% | -66,9 -73,0 8.43% | -58,7 |
EPS USD | Released Forecast Spread | -0,52 | -0,77 -0,83 7.23% | -1,14 -1,17 2.29% | -1,19 -1,30 8.7% | -1,02 |
Announcement Date | 05/03/21 | 10/03/22 | 14/03/23 | 19/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -13,4 -12,3 -8.73% | -15,6 -13,9 -12.42% | -19,2 -16,4 -17.24% | -19,4 -19,3 -0.64% | -21,7 -20,3 -6.41% | -22,6 -22,5 -0.46% | -18,8 -23,8 21.05% | -15,1 -20,0 24.56% | -14,4 -16,9 14.84% | -15,1 | -16,1 | -17,5 | -21,7 | -22,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,3 -12,3 -7.83% | -15,0 -13,9 -7.58% | -17,7 -15,7 -13.11% | -17,3 -18,4 5.76% | -19,3 -20,4 5.21% | -19,9 -22,5 11.36% | -15,8 -23,0 31.21% | -11,8 -19,1 37.85% | -11,1 -17,9 38.1% | -16,1 | -18,3 | -21,4 | -21,7 | -22,0 |
Net income Million USD | Released Forecast Spread | -13,3 -12,1 -9.62% | -15,0 -14,1 -6.17% | -17,7 -15,6 -13.24% | -17,3 -19,3 10.16% | -19,3 -20,7 6.65% | -19,9 -22,9 13.05% | -15,8 -23,8 33.57% | -11,8 -18,0 34.22% | -11,1 -16,1 30.9% | -14,4 | -15,7 | -17,5 | -21,7 | -22,0 |
EPS USD | Released Forecast Spread | -0,24 -0,22 -11.63% | -0,27 -0,25 -6.58% | -0,32 -0,28 -14.29% | -0,31 -0,34 9.71% | -0,35 -0,37 4.55% | -0,36 -0,41 12.2% | -0,28 -0,42 33.33% | -0,21 -0,32 33.68% | -0,20 -0,28 28.57% | -0,25 | -0,27 | -0,30 | -0,36 | -0,36 |
Announcement Date | 09/05/22 | 08/08/22 | 03/11/22 | 14/03/23 | 09/05/23 | 14/08/23 | 13/11/23 | 19/03/24 | 08/05/24 | - | - | - | - | - |
2024-05-15 | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
2024-05-21 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
Past sector events for Design Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DSGN Stock
- Calendar Design Therapeutics, Inc.